Hormone Replacement Therapy Side Effects and What to Watch for

Hormone replacement therapy side effects sort into two groups. The first group is mild and early: breast tenderness, headaches, nausea, bloating, mood changes, fluid retention in the hands and feet, and irregular vaginal bleeding. These usually settle within about three months. The second group is rare but serious: blood clots, stroke, gallbladder disease, and a small change in breast cancer risk with long-term combined therapy.

Below we cover each side effect, how long it lasts, why the delivery method changes the risk more than most people realize, what the numbers actually look like in absolute terms, and what happens when someone stops. We also cover thyroid hormone replacement and hormone therapy for men, since both fall under the same heading and follow the same rules.

What Are the Side Effects of Hormone Replacement Therapy?

The side effects of hormone replacement therapy are breast pain or tenderness, headaches, nausea, bloating and stomach cramps, mood changes, leg cramps, fluid retention in the hands, feet, or lower legs, and irregular vaginal bleeding or spotting. MedlinePlus lists each of these, and the NHS and Cleveland Clinic name the same core set.

These effects sort by which hormone causes them. Estrogen and progesterone act on different tissues, so they produce different complaints, and a woman taking combined therapy can get some from each. Sorting them this way is useful, because it tells the prescriber which part of the prescription to adjust.

A second sorting matters more for safety. Most side effects are mild and fade on their own. A much smaller group carries real risk and depends heavily on the form of hormone used, the type of progestogen, and how many years past menopause a woman starts. Those two groups get treated very differently, and the rest of this article follows that split.

One more point before the detail. A hormonal imbalance produces symptoms in either direction, so a complaint that appears after starting therapy may be a dose that is too high, a dose that is too low, or the menopause itself continuing underneath.

What Are the Most Common Side Effects of HRT?

The most common side effects of HRT are irregular vaginal bleeding, breast tenderness, and mood swings. Cleveland Clinic names those three as the most frequent, with bloating, headaches, skin discoloration, increased breast density, and skin irritation under an estrogen patch listed as less common.

Frequency does not mean severity. The NHS notes that it is common to have no side effects at all, or only mild ones, and advises continuing treatment for at least three months where possible because complaints usually improve over that window.

What Are the Side Effects of Estrogen?

The side effects of estrogen are headaches, breast pain or tenderness, unexpected vaginal bleeding or spotting, nausea, mood changes including low mood, leg cramps, mild rash or itching, diarrhea, and hair loss. The NHS lists all nine and notes they often go away after a few weeks.

Mood changes deserve a note of their own, because they are easy to misread. Falling estrogen during menopause causes mood swings, and estrogen therapy can also cause them at the wrong dose. Two different problems produce the same complaint. Sorting out mood changes takes a conversation about timing rather than a guess.

What Are the Side Effects of Progesterone?

The side effects of progesterone are changes in bleeding pattern including spotting between periods, headaches, breast pain or tenderness, nausea, diarrhea, feeling tired or dizzy, mood changes, mild rash or itchy skin, and acne. The NHS lists these separately from the estrogen set for a reason, since the two hormones can be adjusted independently.

Tiredness and dizziness sit almost entirely on the progesterone side of the list. Women taking combined therapy who feel flat or foggy are often reacting to the progestogen component rather than the estrogen. Existing sleep disorders can amplify that, and MedlinePlus also lists insomnia among the reported effects.

How Long Do HRT Side Effects Last?

Most HRT side effects last a few weeks to three months and then settle on their own. The NHS advises staying with treatment for at least three months where possible, because effects usually improve over that period, and recommends speaking to a doctor if they are severe or continue past three months.

Three months is the reference point for nearly everything that follows. Cleveland Clinic states that side effects typically resolve on their own within a few months, that most are mild, and that in most cases they do not require stopping therapy. What they may require is an adjustment.

Adjustment usually means one of three things: a change in dose, a change in the type of hormone, or a change in how it is taken. The NHS gives switching from tablets to patches as its worked example. That single switch changes more than convenience, as the comparison further down shows.

Why Does Vaginal Bleeding Happen on HRT?

Vaginal bleeding happens on HRT because the hormones act on the lining of the uterus, and the lining responds by shedding on a schedule set by the type of regimen. The NHS reports that irregular bleeding or spotting in the first few months is common and not usually a sign of anything serious.

Regimen sets the pattern. On sequential combined therapy, where progestogen is taken for part of each month, withdrawal bleeding at the end of each course is expected rather than abnormal. On continuous combined therapy, where both hormones are taken daily, irregular bleeding or spotting is common through the first four to six months and then settles.

Timelines give a clear line between normal and worth checking. The NHS advises telling a doctor about irregular bleeding at the three-month review, and seeking advice if bleeding continues beyond six months after starting, becomes heavier, or begins after a stretch with no periods at all.

Does HRT Cause Weight Gain?

HRT does not cause weight gain in most women, and the NHS states there is little evidence that most types of HRT make you put on weight. Weight often rises during menopause and with age whether or not a woman takes hormones.

Attribution is the whole issue. Menopause and HRT produce overlapping symptoms, which is why the NHS notes that side effects of HRT can resemble menopause symptoms closely enough that the therapy may not be the cause at all. MedlinePlus does list appetite and weight changes among reported effects, so the experience is real for some women, but the population evidence does not support weight gain as a general effect.

Fluid retention muddies it further. Swelling in the hands, feet, or lower legs is a listed effect and shows up on a scale as added pounds without any change in fat. Persistent weight changes during this period usually involve thyroid function, insulin, sleep, and muscle loss together, and hormones are one input rather than the whole picture.

What Is the Safest Form of Hormone Replacement Therapy?

The safest form of hormone replacement therapy for most women is transdermal estrogen, meaning a patch, gel, or spray, because it does not carry the increased blood clot risk that oral tablets do. This is one of the most consistently replicated findings in menopause research, and it comes down to a single mechanism.

Oral estrogen travels from the gut to the liver before it reaches the rest of the bloodstream. The liver responds to that first pass by producing more clotting proteins. Clotting proteins raise the chance of a venous thromboembolism, which is a clot in a vein. Transdermal estrogen absorbs through the skin and enters the bloodstream directly, skipping the first pass, and has minimal effect on those clotting measures.

The numbers are striking. In the ESTHER case-control study published in Circulation, current users of oral estrogen had a venous thromboembolism odds ratio of 4.2 compared with non-users, while transdermal users sat at 0.9, meaning no increase. A pooled meta-analysis of 28 observational studies found the same pattern, with oral estrogen at a relative risk of 1.48 and transdermal at 1.01.

FormReported Blood Clot RiskGallbladder RiskNotesOral tabletOdds ratio 1.58 in a UK study of 5,795 clot cases; 4.2 in the ESTHER study2.0 gallbladder surgeries per 100 women over five yearsPasses through the liver first, raising clotting proteinsTransdermal patch, gel, or sprayOdds ratio 0.93, showing no increase over non-use1.3 gallbladder surgeries per 100 women over five yearsSkips the liver first pass; skin irritation possible at the siteVaginal cream, ring, or tabletLocal delivery at much lower doseNot associated at local dosesTreats vaginal dryness; does not treat hot flashesNo hormone therapyReference group1.1 gallbladder surgeries per 100 women over five yearsBaseline for comparison

Sources: Circulation, ESTHER case-control study; BMJ nested case-control study of 5,795 women with venous thromboembolism and 21,670 controls; BMJ prospective cohort on gallbladder disease and hormone therapy; pooled meta-analysis of 28 observational studies (2019).

The progestogen matters as much as the estrogen. In the same UK study, conjugated equine estrogen combined with medroxyprogesterone carried the highest clot risk at an odds ratio of 2.10, while estradiol with dydrogesterone carried the lowest at 1.18. The ESTHER researchers found micronized progesterone at 0.7 and pregnane derivatives at 0.9, both showing no increase, while norpregnane derivatives carried close to a fourfold rise at 3.9. Two prescriptions both called combined HRT can differ by that much.

Are Patch Side Effects Different From Pill Side Effects?

Patch side effects are different from pill side effects in two ways. Patches add skin irritation under the adhesive, which Cleveland Clinic lists among the less common effects, and patches remove the nausea and stomach upset that come from taking estrogen by mouth.

Body weight sharpens the difference. ESTHER data showed that women with obesity taking oral estrogen had a clot odds ratio of 10.2 compared with non-users, while women with obesity on transdermal estradiol showed no significant increase at all.

Do Hormone Pellets Have Different Side Effects?

Hormone pellets carry the same side effects as other forms, with one difference that matters: the dose cannot be adjusted once the pellet is placed under the skin. Every other form allows a dose change within days.

Adjustability is the hinge of this entire article. Most side effects respond to lowering the dose, changing the hormone type, or switching the route. A pellet takes those options off the table for three to six months, so a woman who develops breast tenderness or mood changes in week two waits it out.

That is why we do not recommend hormone pellets in our bioidentical hormone therapy protocols. Release from a pellet is also uneven across its lifespan, which produces levels that run high early and taper later. Creams, gels, capsules, and troches all allow a correction when something is off.

What Are the Serious Risks of HRT?

The serious risks of HRT are blood clots, stroke, gallbladder disease, uterine cancer when estrogen is taken without a progestin by a woman who still has a uterus, and a small increase in breast cancer with long-term combined use. Cleveland Clinic lists each, along with an increased heart disease risk when therapy begins more than ten years after menopause starts.

Absolute numbers give these their proper size. The Women's Health Initiative randomized 16,608 postmenopausal women aged 50 to 79 to combined estrogen and progestin or placebo, and stopped the trial early. Per 10,000 women-years, the combined therapy group had 7 more coronary events, 8 more strokes, 10 more pulmonary embolisms, and 8 more invasive breast cancers, alongside 6 fewer colorectal cancers and 5 fewer hip fractures.

Read another way, those same figures mean 38 women per 10,000 developed breast cancer each year on combined therapy compared with 30 on placebo, and 29 had a stroke compared with 21. The differences are real and they are also small per woman per year. Cleveland Clinic puts the breast cancer increase at under 1 in 1,000 and notes that risk typically does not rise until after five years of use.

One finding gets lost in the summaries. The Women's Health Initiative also ran a separate arm of 10,739 women who had already had a hysterectomy and took estrogen alone. That group showed no observed increase in breast cancer risk compared with placebo. Estrogen alone and estrogen with a synthetic progestin produced different results, which is why the type of prescription matters more than the word "hormones."

Is There a Link Between HRT and Dementia?

A link between HRT and dementia appeared in older labeling as a probable risk, and the FDA removed that specific warning in its 2025 review of menopausal hormone therapy products. The warning came from findings in older women who began therapy well past menopause.

The removal was part of a broader action. On November 10, 2025, the U.S. Department of Health and Human Services and the FDA announced they would initiate removal of boxed warnings covering cardiovascular disease, breast cancer, and probable dementia across menopausal hormone therapy products, following a literature review, a July 2025 expert panel, and a public comment period.

Removal of a warning is not the same as proof of benefit, and researchers continue to study cognition and hormones. The practical reading is narrower: the evidence no longer supported labeling every estrogen product with a dementia warning drawn from one population.

Why Have Some Doctors Been Cautious About HRT?

Some doctors have been cautious about HRT because a single large trial published in 2002 produced alarming headlines, and its findings were applied to every hormone product regardless of type, dose, or delivery route. That trial was the Women's Health Initiative.

Design details explain a great deal. The Women's Health Initiative tested conjugated equine estrogen paired with a synthetic progestin, in oral form, in women whose average age was 63. That is a specific formulation, by the highest-risk route, in a population well past the typical age of starting treatment. The results were then generalized to estradiol patches and micronized progesterone, which behave differently.

Cleveland Clinic addresses the resulting caution directly, noting that providers are not against HRT out of any wish for patients to suffer, but rather are weighing known risks against an individual situation. That is a fair description of good practice, and it is also why the picture has kept changing as the evidence has.

The regulatory position has now moved. Following the November 2025 announcement, 29 drug companies submitted proposed labeling changes, and the FDA has approved a first batch covering six products across all four categories of menopausal hormone therapy. The agency cited randomized data showing reductions in all-cause mortality and fractures among women who begin systemic hormone therapy within ten years of menopause or before age 60.

Two caveats keep this accurate. The boxed warning for endometrial cancer remains in place for systemic estrogen-alone products, according to the Society of Gynecologic Oncology, so not every warning was lifted. And the change has drawn debate among clinicians, some of whom argue the removal went further than the evidence supports for systemic products. A naturopathic medicine approach to this is the same as a conventional one: read the individual situation rather than the headline.

When Is the Best Time to Start HRT?

The best time to start HRT is before age 60 or within ten years of menopause beginning, and Cleveland Clinic states that risks of complications are higher when therapy starts more than ten years after symptoms begin. Taking hormone therapy in the forties or fifties is typically not associated with increased cardiovascular disease risk.

This is the reason age questions come up so often. A woman starting at 52 and a woman starting at 68 are not running the same risk, even on an identical prescription, because the state of the blood vessels differs. The FDA pointed to the same ten-year window when it cited reductions in all-cause mortality and fractures with earlier initiation.

Age also changes the goal. Women who lose estrogen early, before 40, are usually given higher doses to replace what their ovaries would otherwise be producing, and Cleveland Clinic notes that this group faces increased cardiovascular risk if they do not use hormone therapy. Early loss and late start are opposite situations. Our discussion of menopause hormone therapy covers candidacy in more depth.

For women past 60 who want treatment, route becomes the lever. Lower-dose local vaginal therapy treats dryness without meaningful systemic exposure, and transdermal delivery avoids the clot mechanism that concerns clinicians most in this group.

How Long Should a Woman Stay on HRT?

Most women stay on HRT for five years or less, though Cleveland Clinic notes there is no set length of time and duration varies with symptom severity, the type of therapy, and personal preference. There is no fixed stopping age either.

Duration interacts with one specific risk. Breast cancer risk on combined therapy typically does not rise until after five years of use, which is what makes five years a natural review point rather than a hard limit. Regular reassessment matters more than a number.

Review intervals are well defined. MedlinePlus states that a doctor treating menopause symptoms will check every three to six months whether the medication is still needed, and recommends a complete physical at least yearly including blood pressure measurement, breast examination, and a mammogram. Staying on therapy for years is a series of decisions rather than one.

What Are the Side Effects of Stopping Hormone Replacement Therapy?

The side effects of stopping hormone replacement therapy are a return of menopause symptoms, most often hot flashes, night sweats, sleep disruption, mood changes, and vaginal dryness. Stopping does not create new symptoms so much as remove the treatment holding old ones down.

Timing of the return varies. Some women notice symptoms within days of stopping, others over several weeks, and some find that symptoms have genuinely eased with time and do not come back at full strength. The only way to know which applies is to stop under supervision rather than abruptly.

A structured approach makes the difference:

1. Raise the intention with the prescriber before stopping, not after symptoms return.
2. Ask whether a gradual dose reduction fits your situation better than stopping outright.
3. Track symptoms in writing across the first eight weeks, so the pattern is visible rather than remembered.
4. Keep any scheduled review appointment during the transition period.
5. Revisit the decision at three months, when the picture is clear enough to judge.

Cleveland Clinic advises never making changes to the medication or stopping it without talking to a provider. That applies to stopping as much as to adjusting.

What Happens If You Don't Take Estrogen During Menopause?

If you don't take estrogen during menopause, symptoms such as hot flashes, night sweats, vaginal dryness, sleep disruption, and mood changes continue until they ease on their own, and bone loss proceeds without the protective effect estrogen provides. Cleveland Clinic lists reduced osteoporosis and fracture risk among the benefits of hormone therapy.

Bone is the clearest long-term difference. Estrogen slows the rate at which bone is broken down, so losing it accelerates thinning, which is why estrogen therapy is approved in part for osteoporosis prevention. Women who lose estrogen before 45 through surgical removal of the ovaries face that acceleration decades earlier than usual.

Aging itself is not driven by estrogen alone, despite how the question is often framed. Skin thinning, muscle loss, sleep quality, and cardiovascular change all involve multiple systems, and healthy aging depends on nutrition, movement, sleep, and metabolic health alongside hormone status. Going without estrogen has real consequences, and it does not make a person age faster in every sense.

‍

What Should You Avoid While on HRT?

While on HRT you should avoid smoking, adjusting your own dose, skipping scheduled reviews and mammograms, and ignoring the specific warning symptoms that call for immediate medical attention. MedlinePlus notes that smoking while taking these medications may increase the risk of serious effects such as blood clots and stroke.

The working list is short:

• Do not smoke. It compounds the clot and stroke risk that the hormones already carry.
• Do not change or stop your dose without speaking to the prescriber first.
• Do not skip the three-to-six-month reviews or the yearly physical, breast exam, and mammogram.
• Do not start St. John's wort or new supplements without telling the prescriber, since MedlinePlus flags an interaction with estrogen and progestin.
• Do not dismiss bleeding that continues past six months, becomes heavier, or begins after a stretch without periods.
• Do not wait on the serious warning signs. MedlinePlus lists sudden severe headache, speech problems, sudden vision loss, weakness or numbness in an arm or leg, chest pain or heaviness, sudden shortness of breath, and pain, tenderness, or redness in one leg as reasons to call a doctor immediately.
• Do not assume a new breast lump or nipple discharge can wait for the next scheduled visit.

How Can You Lower the Risk of HRT Side Effects?

You lower the risk of HRT side effects by choosing a delivery route that avoids the liver, using the lowest effective dose, matching the progestogen to the risk profile, starting within the recommended window, and testing on a set schedule. Each of those choices moves a specific number rather than offering general reassurance.

Route is the largest single lever, and the table above shows why. Dose is the second. Cleveland Clinic describes beginning with the lowest effective dose, meaning the smallest amount that relieves symptoms, and most early side effects respond to a reduction rather than to stopping.

Preparation is the lever most often overlooked. The clot data separates estradiol from conjugated equine estrogen, and micronized progesterone from synthetic progestins and norpregnane derivatives. Both estradiol and micronized progesterone are bioidentical, meaning molecularly identical to what the body produces, and both are available in FDA-approved forms. The choice between preparations is a safety decision, not a branding one.

Testing before and during treatment is what makes the rest of it adjustable. At our Bingham Farms office we look at hormone levels alongside hormone metabolites, liver detoxification pathways, nutrient status, inflammatory markers, and thyroid function, because several of those affect how a woman responds to a given dose.

Root causes belong in the same conversation. Thyroid dysfunction, insulin resistance, chronic stress, poor sleep, and endocrine-disrupting chemical exposure all produce symptoms that overlap with menopause and all change how hormone therapy performs. Our advanced lab testing is built to separate those threads before a prescription is written.

When hormone therapy is the right tool, that groundwork makes it safer. Our approach to hormone therapy uses molecularly identical hormones with delivery methods that hold levels steady and allow adjustment, which is the same reason we avoid pellets.

What Are the Side Effects of Thyroid Hormone Replacement Therapy?

Sex hormones are one branch of hormone replacement. Thyroid hormone is another, and it follows the same dose logic. The side effects of thyroid hormone replacement therapy come almost entirely from over-replacement, and they include palpitations, anxiety, tremor, irritability, insomnia, heat intolerance, and unintended weight loss.

Over-replacement is more common than most patients expect. Research drawing on the Baltimore Longitudinal Study of Aging and related work found that up to 40 percent of adults on thyroid hormone replacement are not in the target range, with 10 to 20 percent overtreated. In older patients, reported overtreatment rates have ranged from 9.6 percent to 50 percent.

Two consequences carry the most weight. Suppressing thyroid stimulating hormone below 0.4 mIU/L has been associated with a threefold to fivefold rise in atrial fibrillation risk, particularly over age 60. The levothyroxine label also warns of increased bone resorption and decreased bone mineral density with over-replacement, especially in postmenopausal women, which stacks on top of the bone changes menopause already brings.

Both consequences argue for the same thing, which is testing rather than symptom-guessing. Assessing thyroid issues means reading full thyroid function rather than a single number in isolation.

Full panels are standard practice for the patients we see across the greater Detroit area, whether or not thyroid hormone is already part of the picture.

What Are the Side Effects of Hormone Replacement Therapy in Men?

The side effects of hormone replacement therapy in men are acne and oily skin, fluid retention, breast tenderness or enlargement, worsening sleep apnea, smaller testicles, a lower sperm count, and a rise in red blood cell count that shows up only on a blood test. Testosterone is the hormone involved, and the pattern will look familiar by now.

Dose and route govern the outcome again. Injectable testosterone produces higher peaks and a substantially higher rate of elevated red blood cell counts than gels do, and pellets present the same adjustability problem in men that they present in women. The red cell rise is the effect that requires monitoring, because it produces no symptoms until it is well established.

The through-line across all three branches is the same. Whether the hormone is estrogen, thyroid hormone, or testosterone, side effects track the dose, the delivery route, and whether anyone is checking. Men considering bioidentical hormones face the same three questions women do.

Frequently Asked Questions

Who Should Not Take HRT?

Women who should not take HRT include those who have or have had breast cancer, ovarian cancer, or uterine cancer, those with abnormal vaginal bleeding, those who have had blood clots or are at high risk, those with a history of stroke, heart attack, or increased cardiovascular risk, those who are pregnant, and those with gallbladder or liver disease. Cleveland Clinic lists each of these.

Does HRT Cause Breast Cancer?

HRT has been associated with a small increase in breast cancer risk with long-term combined use, and Cleveland Clinic puts that increase at less than 1 in 1,000 with risk typically not rising until after five years. In the Women's Health Initiative, 38 women per 10,000 per year developed breast cancer on combined therapy compared with 30 on placebo. The estrogen-alone arm showed no observed increase.

Are Bioidentical Hormones Safer Than Synthetic Hormones?

Bioidentical hormones are a type of HRT that more closely matches the estrogen and progesterone the body produces, and several are available in FDA-approved forms including estradiol and micronized progesterone. The clot data does separate these preparations from conjugated equine estrogen and synthetic progestins. Cleveland Clinic notes that custom compounded hormones are less well studied than FDA-approved options.

How Does a Woman Feel With No Estrogen?

A woman with no estrogen commonly feels hot flashes, night sweats, vaginal dryness, disrupted sleep, mood swings or irritability, and low energy. Cleveland Clinic lists these among the symptoms that arise as the ovaries stop producing high levels of estrogen. Intensity varies widely between women and generally eases over years.

Does a 70 Year Old Woman Still Have Estrogen?

A 70 year old woman still has estrogen, though at much lower levels than before menopause. After the ovaries stop producing it, small amounts continue to be made in fat tissue and the adrenal glands. Those levels are enough to be measurable and not enough to prevent the symptoms and bone changes associated with menopause.

What Is the Difference Between HRT and Hormone Therapy?

The difference between HRT and hormone therapy is mostly one of scope and age. Cleveland Clinic explains that hormone therapy is the broader term covering any treatment involving hormones, including cancer treatment, while hormone replacement therapy usually refers to replacing hormones the body no longer makes, particularly in women in their thirties or early forties. Providers often use the terms interchangeably for menopause.

Do Side Effects Mean the HRT Dose Is Wrong?

Side effects do not always mean the HRT dose is wrong, since many appear in the first weeks at an appropriate dose and settle within about three months. Effects that persist past three months, or that are severe at any point, are worth reviewing with the prescriber. The usual response is a change in dose, hormone type, or delivery route rather than stopping.

Putting It All Together

Hormone replacement therapy side effects are mostly mild, mostly early, and mostly self-limiting within about three months. The serious risks are real but small in absolute terms, and they are not fixed. Route changes them, since transdermal estrogen avoids the liver pass that raises clotting proteins. Preparation changes them, since estradiol and micronized progesterone carry different data than conjugated equine estrogen and synthetic progestins. Timing changes them, since starting before 60 or within ten years of menopause carries a different profile than starting later. Dose changes nearly all of them.

The same logic holds across hormone types. Thyroid hormone replacement causes trouble mainly through over-replacement, and testosterone therapy in men follows the dose and route pattern just as closely. What ties the three together is monitoring, because the effects that matter most are the ones a person cannot feel. The FDA's 2025 labeling changes shifted how these risks are communicated, and they did not remove the case for careful oversight.

If you are weighing hormone therapy, already taking it and dealing with side effects, or thinking about stopping, we are glad to look at the whole picture with you. Cutler Integrative Medicine has worked with women and men on root-cause hormone care for over fifteen years. Our practice is based in Bingham Farms.

You are welcome to schedule a consultation whenever the timing suits you.